Zai Lab Ltd (ZLAB) stock
ZLABNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30471% above fair value
$24.60−1.44 (-5.53%)
Close on Nov 13, 2026Market cap $3.82BP/E –Yield –
Zai Lab enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Zai Lab's enterprise value was $2.59B on Nov 11, 2026, against $1.74B a year earlier. Over the last 5 years it ranged from $729.69M to $4.42B, with a median of $2.07B.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $2.59B | +80.0% |
| 2025 | Dec 31, 2025 | $1.44B | -30.8% |
| 2024 | Dec 31, 2024 | $2.07B | +13.5% |
| 2023 | Dec 29, 2023 | $1.83B | +0.1% |
| 2022 | Dec 30, 2022 | $1.83B | -58.7% |
| 2021 | Dec 31, 2021 | $4.42B | -54.3% |
| 2020 | Dec 31, 2020 | $9.68B | +286.4% |
| 2019 | Dec 31, 2019 | $2.50B | +169.4% |
| 2018 | Dec 31, 2018 | $929.31M | +667.6% |
| 2017 | Dec 29, 2017 | $121.07M | – |
See a number that looks wrong?